1. 2020
  2. Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription. / Pannus, Pieter; Rutsaert, Sofie; De Wit, Stéphane; Allard, Sabine D; Vanham, Guido; Cole, Basiel; Nescoi, Coca; Aerts, Joeri; De Spiegelaere, Ward; Tsoumanis, Achilleas; Couttenye, Marie-Madeleine; Herssens, Natacha; De Scheerder, Marie-Angélique; Vandekerckhove, Linos; Florence, Eric.

    In: Journal of the International AIDS Society, Vol. 23, No. 2, 2020, p. e25453.

    Research output: Contribution to journalA1: Web of Science-article

  3. The COVID-19 pandemic: diverse contexts; different epidemics-how and why? / Van Damme, Wim; Dahake, Ritwik; Delamou, Alexandre; Ingelbeen, Brecht; Wouters, Edwin; Vanham, Guido; van de Pas, Remco; Dossou, Jean-Paul; Ir, Por; Abimbola, Seye; Van der Borght, Stefaan; Narayanan, Devadasan; Bloom, Gerald; Van Engelgem, Ian; Ag Ahmed, Mohamed Ali; Kiendrébéogo, Joël Arthur; Verdonck, Kristien; De Brouwere, Vincent; Bello, Kéfilath; Kloos, Helmut; Aaby, Peter; Kalk, Andreas; Al-Awlaqi, Sameh; Prashanth, N S; Muyembe-Tamfum, Jean-Jacques; Mbala, Placide; Ahuka-Mundeke, Steve; Assefa, Yibeltal.

    In: BMJ Global Health , Vol. 5, No. 7, 2020.

    Research output: Contribution to journalA1: Web of Science-article

  4. 2019
  5. Increased frequency of cytotoxic CXCR5+effector memory CD8+T cells during natural control of HIV-1 infection. / Adams, P.; Iserentant, G.; Servais, J-Y; Pannus, P.; Rutsaert, S.; Van Frankehuijsen, M.; De Wit, S.; Allard, S. D.; Messiaen, P.; Moutschen, M.; Aerts, J. L.; Vandekerckhove, L.; Vanham, G.; Devaux, C.

    In: HIV Medicine, Vol. 20, 2019, p. 42-43.

    Research output: Contribution to journalConference abstract in journal

  6. Therapeutic vaccine in chronically HIV-1-infected patients: a randomized, double-blind, placebo-controlled phase IIa trial with HTI-TriMix. / Jong, Wesley de; Leal, Lorna; Buyze, Jozefien; Pannus, Pieter; Guardo, Alberto; Salgado, Maria; Mothe, Beatriz; Molto, Jose; Moron-Lopez, Sara; Gálvez, Cristina; Florence, Eric; Vanham, Guido; Gorp, Eric van; Brander, Christian; Allard, Sabine; Thielemans, Kris; Martinez-Picado, Javier; Plana, Montserrat; García, Felipe; Gruters, Rob A.

    In: Vaccines, Vol. 7, No. 4, 2019.

    Research output: Contribution to journalA1: Web of Science-article

  7. In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8(+) T cells in treated HIV-positive patients. / Pannus, Pieter; Adams, Philipp; Willems, Elisabeth; Heyndrickx, Leo; Florence, Eric; Rutsaert, Sofie; De Spiegelaere, Ward; Vandekerckhove, Linos; Seguin-Devaux, Carole; Vanham, Guido.

    In: AIDS, Vol. 33, No. 3, 2019, p. 387-398.

    Research output: Contribution to journalA1: Web of Science-article

  8. Viral inhibitory activity of CD8+T cells in HIV infection. / Pannus, Pieter; Vanham, Guido.

    In: AIDS Reviews, Vol. 21, No. 3, 2019, p. 115-125.

    Research output: Contribution to journalA1: Web of Science-article

  9. 2018
  10. Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection. / iHIVARNA Consortium.

    In: AIDS, Vol. 32, No. 17, 2018, p. 2533-2545.

    Research output: Contribution to journalA1: Web of Science-article

  11. Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients. / Adriaensen, Wim; Dorlo, Thomas P C; Vanham, Guido; Kestens, Luc; Kaye, Paul M; van Griensven, Johan.

    In: Frontiers in Immunology, Vol. 8, 2018, p. 1943.

    Research output: Contribution to journalA1: Web of Science-article

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 4718